Review Article
Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells
Table 2
Off-target effect of CSC-targeting inhibitors on immune cells.
| Inhibition of CSC pathways, function and markers | Off targeting effect on immune cells | Reference |
| β-catenin | Impairs polarization, differentiation, and maturation of T cells | [23, 24] | Notch receptor | Blocks cytotoxic T cells’ function and cytotoxin production | [19, 20] | WnT receptor | Inhibits CD8 positive T cell’s development | [23, 24] | Hedgehog receptor | Inhibits myeloid-derived suppressor cell function | [30] | ABCB complex | Inhibits transporter associated with antigen processing (TAP) in antigen-presenting cells | [69] | ALDH | Inhibits regulatory T cells’ function | [52] | IL-6 receptor | Impairs central and naïve memory T cells’ proliferation, survival, and effector function | [59] | CD44 | Impairs Th1 cell survival, memory, effector function, and IFNγ production | [60, 61] |
|
|